UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Neurotoxic effects of anesthetics on the developing brain

Authors
Richard J Levy, MD, FAAP
Caleb Ing, MD, MS
Section Editors
Lena S Sun, MD
Andrew Davidson, MD
Deputy Editor
Marianna Crowley, MD

INTRODUCTION

The possibility that anesthetic and sedative drugs may be neurotoxic to the developing brain is of widespread importance to patients, parents, and the clinicians who care for them. This topic will discuss the neuronal damage and neurodevelopmental changes that have been reported after exposure of the developing brain to anesthetics in animal and human studies, the proposed mechanisms for these effects, and the limitations of existing literature.

THE ISSUE

Studies in animals have shown that anesthetic and sedative drugs can cause neuronal damage to the developing brain, and can cause lasting behavioral and cognitive deficits. Some human studies suggest an association between exposure of young children to anesthesia and subsequent neurodevelopmental deficits, though causation has not been established, and the specific anesthetic and patient factors that may affect risk are unknown. While concerns have also been raised regarding anesthetic exposure of the developing brain in utero, there is currently little to no evidence in humans to support these concerns.

Any degree of neurotoxicity of anesthetic and sedative drugs in humans may have widespread implications. In the United States, there are over 1.3 million children under the age of five years who undergo surgical procedures each year [1,2]. Most of these children need and receive general anesthesia, and most of these procedures cannot be delayed without adding substantial risk. In addition, an increasing number of young children receive sedatives or general anesthesia for neuroimaging studies [3], and many more require procedural sedation in the emergency department.

PROPOSED MECHANISMS

Much of the research on the mechanisms of anesthetic neurotoxicity has focused on apoptosis, though it is now evident that other mechanisms may be involved.

Oxidative stress associated apoptosis Anesthetic agents cause neuronal oxidative stress by inducing reactive oxygen species (ROS) formation within mitochondria during exposure [4,5]. ROS produced in this setting permit cytochrome c mobilization from the inner mitochondrial membrane [6,7]. Simultaneously, the outer mitochondrial membrane becomes permeable following anesthetic-mediated gamma-aminobutyric acidA (GABAA) receptor stimulation and N-methyl-D-aspartate (NMDA) receptor antagonism [8]. The combination of these events allows cytochrome c to be released into the cytosol and sets in motion a cascade of cellular events that ultimately leads to apoptotic neuronal cell death.

          
To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Oct 2017. | This topic last updated: Jul 06, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Rabbitts JA, Groenewald CB, Moriarty JP, Flick R. Epidemiology of ambulatory anesthesia for children in the United States: 2006 and 1996. Anesth Analg 2010; 111:1011.
  2. Tzong KY, Han S, Roh A, Ing C. Epidemiology of pediatric surgical admissions in US children: data from the HCUP kids inpatient database. J Neurosurg Anesthesiol 2012; 24:391.
  3. Bjur KA, Payne ET, Nemergut ME, et al. Anesthetic-Related Neurotoxicity and Neuroimaging in Children: A Call for Conversation. J Child Neurol 2017; 32:594.
  4. Bai X, Yan Y, Canfield S, et al. Ketamine enhances human neural stem cell proliferation and induces neuronal apoptosis via reactive oxygen species-mediated mitochondrial pathway. Anesth Analg 2013; 116:869.
  5. Zhang Y, Dong Y, Wu X, et al. The mitochondrial pathway of anesthetic isoflurane-induced apoptosis. J Biol Chem 2010; 285:4025.
  6. Kapetanaki SM, Silkstone G, Husu I, et al. Interaction of carbon monoxide with the apoptosis-inducing cytochrome c-cardiolipin complex. Biochemistry 2009; 48:1613.
  7. Hofacer RD, Deng M, Ward CG, et al. Cell age-specific vulnerability of neurons to anesthetic toxicity. Ann Neurol 2013; 73:695.
  8. Olney JW, Young C, Wozniak DF, et al. Anesthesia-induced developmental neuroapoptosis. Does it happen in humans? Anesthesiology 2004; 101:273.
  9. Vutskits L, Gascon E, Tassonyi E, Kiss JZ. Effect of ketamine on dendritic arbor development and survival of immature GABAergic neurons in vitro. Toxicol Sci 2006; 91:540.
  10. Erasso DM, Camporesi EM, Mangar D, Saporta S. Effects of isoflurane or propofol on postnatal hippocampal neurogenesis in young and aged rats. Brain Res 2013; 1530:1.
  11. Olsen EA, Brambrink AM. Anesthetic neurotoxicity in the newborn and infant. Curr Opin Anaesthesiol 2013; 26:535.
  12. Ma R, Wang X, Peng P, et al. α-Lipoic acid inhibits sevoflurane-induced neuronal apoptosis through PI3K/Akt signalling pathway. Cell Biochem Funct 2016; 34:42.
  13. Johnson SA, Young C, Olney JW. Isoflurane-induced neuroapoptosis in the developing brain of nonhypoglycemic mice. J Neurosurg Anesthesiol 2008; 20:21.
  14. Disma N, Mondardini MC, Terrando N, et al. A systematic review of methodology applied during preclinical anesthetic neurotoxicity studies: important issues and lessons relevant to the design of future clinical research. Paediatr Anaesth 2016; 26:6.
  15. Loepke AW, Soriano SG. An assessment of the effects of general anesthetics on developing brain structure and neurocognitive function. Anesth Analg 2008; 106:1681.
  16. Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003; 23:876.
  17. Istaphanous GK, Loepke AW. General anesthetics and the developing brain. Curr Opin Anaesthesiol 2009; 22:368.
  18. Raper J, Alvarado MC, Murphy KL, Baxter MG. Multiple Anesthetic Exposure in Infant Monkeys Alters Emotional Reactivity to an Acute Stressor. Anesthesiology 2015; 123:1084.
  19. Coleman K, Robertson ND, Dissen GA, et al. Isoflurane Anesthesia Has Long-term Consequences on Motor and Behavioral Development in Infant Rhesus Macaques. Anesthesiology 2017; 126:74.
  20. Creeley CE, Dikranian KT, Dissen GA, et al. Isoflurane-induced apoptosis of neurons and oligodendrocytes in the fetal rhesus macaque brain. Anesthesiology 2014; 120:626.
  21. Zou X, Liu F, Zhang X, et al. Inhalation anesthetic-induced neuronal damage in the developing rhesus monkey. Neurotoxicol Teratol 2011; 33:592.
  22. Brambrink AM, Evers AS, Avidan MS, et al. Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain. Anesthesiology 2010; 112:834.
  23. Brambrink AM, Evers AS, Avidan MS, et al. Ketamine-induced neuroapoptosis in the fetal and neonatal rhesus macaque brain. Anesthesiology 2012; 116:372.
  24. Zou X, Patterson TA, Divine RL, et al. Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int J Dev Neurosci 2009; 27:727.
  25. Slikker W Jr, Zou X, Hotchkiss CE, et al. Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol Sci 2007; 98:145.
  26. Creeley C, Dikranian K, Dissen G, et al. Propofol-induced apoptosis of neurones and oligodendrocytes in fetal and neonatal rhesus macaque brain. Br J Anaesth 2013; 110 Suppl 1:i29.
  27. Mintz CD, Wagner M, Loepke AW. Preclinical research into the effects of anesthetics on the developing brain: promises and pitfalls. J Neurosurg Anesthesiol 2012; 24:362.
  28. Istaphanous GK, Ward CG, Loepke AW. The impact of the perioperative period on neurocognitive development, with a focus on pharmacological concerns. Best Pract Res Clin Anaesthesiol 2010; 24:433.
  29. van Loo KM, Martens GJ. Genetic and environmental factors in complex neurodevelopmental disorders. Curr Genomics 2007; 8:429.
  30. Workman AD, Charvet CJ, Clancy B, et al. Modeling transformations of neurodevelopmental sequences across mammalian species. J Neurosci 2013; 33:7368.
  31. Zhang H, Du L, Du Z, et al. Association between childhood exposure to single general anesthesia and neurodevelopment: a systematic review and meta-analysis of cohort study. J Anesth 2015; 29:749.
  32. DiMaggio C, Sun LS, Ing C, Li G. Pediatric anesthesia and neurodevelopmental impairments: a Bayesian meta-analysis. J Neurosurg Anesthesiol 2012; 24:376.
  33. Davidson AJ, Disma N, de Graaff JC, et al. Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial. Lancet 2016; 387:239.
  34. O'Leary JD, Janus M, Duku E, et al. A Population-based Study Evaluating the Association between Surgery in Early Life and Child Development at Primary School Entry. Anesthesiology 2016; 125:272.
  35. Graham MR, Brownell M, Chateau DG, et al. Neurodevelopmental Assessment in Kindergarten in Children Exposed to General Anesthesia before the Age of 4 Years: A Retrospective Matched Cohort Study. Anesthesiology 2016; 125:667.
  36. Glatz P, Sandin RH, Pedersen NL, et al. Association of Anesthesia and Surgery During Childhood With Long-term Academic Performance. JAMA Pediatr 2017; 171:e163470.
  37. Flick RP, Katusic SK, Colligan RC, et al. Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics 2011; 128:e1053.
  38. Ing CH, DiMaggio CJ, Malacova E, et al. Comparative analysis of outcome measures used in examining neurodevelopmental effects of early childhood anesthesia exposure. Anesthesiology 2014; 120:1319.
  39. Beers SR, Rofey DL, McIntyre KA. Neurodevelopmental assessment after anesthesia in childhood: review of the literature and recommendations. Anesth Analg 2014; 119:661.
  40. Wilder RT, Flick RP, Sprung J, et al. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology 2009; 110:796.
  41. Hu D, Flick RP, Zaccariello MJ, et al. Association between Exposure of Young Children to Procedures Requiring General Anesthesia and Learning and Behavioral Outcomes in a Population-based Birth Cohort. Anesthesiology 2017; 127:227.
  42. DiMaggio C, Sun LS, Kakavouli A, et al. A retrospective cohort study of the association of anesthesia and hernia repair surgery with behavioral and developmental disorders in young children. J Neurosurg Anesthesiol 2009; 21:286.
  43. DiMaggio C, Sun LS, Li G. Early childhood exposure to anesthesia and risk of developmental and behavioral disorders in a sibling birth cohort. Anesth Analg 2011; 113:1143.
  44. Sprung J, Flick RP, Katusic SK, et al. Attention-deficit/hyperactivity disorder after early exposure to procedures requiring general anesthesia. Mayo Clin Proc 2012; 87:120.
  45. Sun LS, Li G, Miller TL, et al. Association Between a Single General Anesthesia Exposure Before Age 36 Months and Neurocognitive Outcomes in Later Childhood. JAMA 2016; 315:2312.
  46. Ing C, DiMaggio C, Whitehouse A, et al. Long-term differences in language and cognitive function after childhood exposure to anesthesia. Pediatrics 2012; 130:e476.
  47. Heyer DB, Meredith RM. Environmental toxicology: Sensitive periods of development and neurodevelopmental disorders. Neurotoxicology 2017; 58:23.
  48. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979; 3:79.
  49. Sanno H, Shen X, Kuru N, et al. Control of postnatal apoptosis in the neocortex by RhoA-subfamily GTPases determines neuronal density. J Neurosci 2010; 30:4221.
  50. Yon JH, Daniel-Johnson J, Carter LB, Jevtovic-Todorovic V. Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience 2005; 135:815.
  51. Casey BJ, Tottenham N, Liston C, Durston S. Imaging the developing brain: what have we learned about cognitive development? Trends Cogn Sci 2005; 9:104.
  52. Ing CH, DiMaggio CJ, Whitehouse AJ, et al. Neurodevelopmental outcomes after initial childhood anesthetic exposure between ages 3 and 10 years. J Neurosurg Anesthesiol 2014; 26:377.
  53. Cattano D, Young C, Straiko MM, Olney JW. Subanesthetic doses of propofol induce neuroapoptosis in the infant mouse brain. Anesth Analg 2008; 106:1712.
  54. Young C, Jevtovic-Todorovic V, Qin YQ, et al. Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br J Pharmacol 2005; 146:189.
  55. Sprung J, Flick RP, Wilder RT, et al. Anesthesia for cesarean delivery and learning disabilities in a population-based birth cohort. Anesthesiology 2009; 111:302.
  56. FDA Drug Safety Communication: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women. 2016. http://www.fda.gov/Drugs/DrugSafety/ucm532356.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery (Accessed on January 03, 2017).
  57. https://www.fda.gov/Drugs/DrugSafety/ucm554634.htm.
  58. Response to the FDA Med Watch December 16, 2016. 2016. http://www.pedsanesthesia.org/wp-content/uploads/2017/01/Response-to-FDA-12-16-Statement_6.pdf (Accessed on March 20, 2017).
  59. ractice Advisory: FDA warnings regarding use of general anesthetics and sedation drugs in young children and pregnant women. The American College of Obstetricians and Gynecologists. December 21, 2016 http://www.acog.org/About-ACOG/News-Room/Practice-Advisories/FDA-Warnings-Regarding-Use-of-General-A.
  60. Consensus Statement on the Use of Anesthetic and Sedative Drugs in Infants and Toddlers. 2015. http://smarttots.org/wp-content/uploads/2015/10/ConsensusStatementV910.5.2015.pdf (Accessed on March 20, 2017).
  61. Andropoulos DB, Greene MF. Anesthesia and Developing Brains - Implications of the FDA Warning. N Engl J Med 2017; 376:905.